DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • India
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
ANTHEM logo

Anthem Biosciences Limited Stock Price

NSEI:ANTHEM Community·₹529.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ANTHEM Share Price Performance

₹940.90
105.45 (12.62%)
​
₹884.43
Fair Value
₹940.90
105.45 (12.62%)
6.4% overvalued intrinsic discount
₹884.43
Fair Value
Price ₹940.90
AnalystConsensusTarget ₹884.43
Tue, 28 Jul 26
Fair Value₹884.43
Share Pricen/a

ANTHEM Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value ₹884.43 6.4% overvalued intrinsic discount

Capacity Expansion And Modalities Shift Will Support Stronger Long-Term Earnings Visibility

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
ANTHEM logo
Anthem Biosciences
6.4% overvalued intrinsic discount

Capacity Expansion And Modalities Shift Will Support Stronger Long-Term Earnings Visibility

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Published 28 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
ANTHEM logo

Capacity Expansion And Modalities Shift Will Support Stronger Long-Term Earnings Visibility

Fair Value: ₹884.43 6.4% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet with high growth potential.

0 Risks
2 Rewards
View Full Analysis

Anthem Biosciences Limited Key Details

₹20.1b

Revenue

₹7.7b

Cost of Revenue

₹12.4b

Gross Profit

₹6.6b

Other Expenses

₹5.8b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
10.23
61.66%
28.69%
1.8%
View Full Analysis

About ANTHEM

Founded
2006
Employees
2282
CEO
Ajay Bhardwaj
WebsiteView website
anthembio.com

Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to commercial manufacturing for small molecules and biologics. It also manufactures and sells specialized fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company was incorporated in 2006 and is based in Bengaluru, India.

Recent ANTHEM News & Updates

User avatar
New Narrative • Jul 28

Capacity Expansion And Modalities Shift Will Support Stronger Long-Term Earnings Visibility

Catalysts About Anthem Biosciences Anthem Biosciences is a contract research, development and manufacturing organization with a large focus on CRDMO services and specialty ingredients across small molecules, peptides, fermentation and related modalities. What are the underlying business or industry changes driving this perspective?
Analysis Article • Jul 24

Anthem Biosciences Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Investors in Anthem Biosciences Limited ( NSE:ANTHEM ) had a good week, as its shares rose 2.5% to close at ₹778...
Analysis Article • Jul 21

With EPS Growth And More, Anthem Biosciences (NSE:ANTHEM) Makes An Interesting Case

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Recent updates

No updates

Anthem Biosciences Limited Competitors

SUNPHARMA logo

Sun Pharmaceutical Industries

Symbol: NSEI:SUNPHARMA
Market cap: ₹4.4t
DIVISLAB logo

Divi's Laboratories

Symbol: NSEI:DIVISLAB
Market cap: ₹2.5t
500420 logo

Torrent Pharmaceuticals

Symbol: BSE:500420
Market cap: ₹1.9t
ZYDUSLIFE logo

Zydus Lifesciences

Symbol: NSEI:ZYDUSLIFE
Market cap: ₹1.1t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide